Project Details
| Status | Active |
|---|---|
| Effective start/end date | 6/19/20 → 6/18/24 |
Funding
- Pfizer, Inc.: $2,239,069.42
A Phase 1/2, Placebo-Controlled, Randomized, Observer-Blind, Dose Finding Study To Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of SARS-CoV-2 RNA Vaccine Candidates against COVID 19 in Healthy Adults
- Rupp, Richard (PI)
Project: Other project